HRS-2300

N/A

Report date: 2024/09/22 20:00:05
NME

Base Information

Drug NameHRS-2300
Drug Alias NameHRS-2300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell proliferation inhibitors
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSolid tumoursNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A